MedTrace Logo

The Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS)

NCT03343470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2022-11-23

No results posted yet for this study

Summary

This is an observational, open, prospective multi-centre study designed to evaluate melatonin and cortisol circadian rhythm, immunological profile and anthropometric parameters in Cushing Syndrome patients during active Remission state.

Conditions

  • Cushing Syndrome

Sponsors & Collaborators

  • Federico II University

    collaborator OTHER

  • University of Palermo

    collaborator OTHER

  • University of Florence

    collaborator OTHER

  • Ospedali Riuniti Ancona

    collaborator OTHER

  • University of Padova

    collaborator OTHER

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Andrea M Isidori, MD, PhD · Dept. Experimental Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03343470 on ClinicalTrials.gov